These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33221389)

  • 1. Development of pyrimidone D1 dopamine receptor positive allosteric modulators.
    Luderman KD; Jain P; Benjamin Free R; Conroy JL; Aubé J; Sibley DR; Frankowski KJ
    Bioorg Med Chem Lett; 2021 Jan; 31():127696. PubMed ID: 33221389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.
    Felsing DE; Jain MK; Allen JA
    Curr Top Med Chem; 2019; 19(16):1365-1380. PubMed ID: 31553283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
    Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
    Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Positive Allosteric Modulators of the D
    Luderman KD; Conroy JL; Free RB; Southall N; Ferrer M; Sanchez-Soto M; Moritz AE; Willette BKA; Fyfe TJ; Jain P; Titus S; Hazelwood LA; Aubé J; Lane JR; Frankowski KJ; Sibley DR
    Mol Pharmacol; 2018 Oct; 94(4):1197-1209. PubMed ID: 30068735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders.
    Svensson KA; Hao J; Bruns RF
    Adv Pharmacol; 2019; 86():273-305. PubMed ID: 31378255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
    Abi-Dargham A; Javitch JA; Slifstein M; Anticevic A; Calkins ME; Cho YT; Fonteneau C; Gil R; Girgis R; Gur RE; Gur RC; Grinband J; Kantrowitz J; Kohler C; Krystal J; Murray J; Ranganathan M; Santamauro N; Van Snellenberg J; Tamayo Z; Wolf D; ; Gray D; Lieberman J
    Schizophr Bull; 2022 Jan; 48(1):199-210. PubMed ID: 34423843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor.
    Li H; Urs NM; Horenstein N
    J Comput Aided Mol Des; 2023 Jun; 37(5-6):227-244. PubMed ID: 37060492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport.
    Gildea JJ; Shah IT; Van Sciver RE; Israel JA; Enzensperger C; McGrath HE; Jose PA; Felder RA
    Kidney Int; 2014 Jul; 86(1):118-26. PubMed ID: 24552847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.
    Shen J; Zhang L; Song WL; Meng T; Wang X; Chen L; Feng LY; Xu YC; Shen JK
    Acta Pharmacol Sin; 2013 Mar; 34(3):441-52. PubMed ID: 23334237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
    Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
    Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D
    Fyfe TJ; Scammells PJ; Lane JR; Capuano B
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Dopamine D1-Like Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys.
    Czoty PW; Nader MA
    J Pharmacol Exp Ther; 2021 Oct; 379(1):12-19. PubMed ID: 34272270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.
    Meltzer HY; Rajagopal L; Matrisciano F; Hao J; Svensson KA; Huang M
    Behav Brain Res; 2019 Apr; 361():139-150. PubMed ID: 30521930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand recognition and biased agonism of the D1 dopamine receptor.
    Teng X; Chen S; Nie Y; Xiao P; Yu X; Shao Z; Zheng S
    Nat Commun; 2022 Jun; 13(1):3186. PubMed ID: 35676276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor.
    Gray DL; Allen JA; Mente S; O'Connor RE; DeMarco GJ; Efremov I; Tierney P; Volfson D; Davoren J; Guilmette E; Salafia M; Kozak R; Ehlers MD
    Nat Commun; 2018 Feb; 9(1):674. PubMed ID: 29445200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective dopamine D
    Nesbit MO; Chai A; Axerio-Cilies P; Phillips AG; Wang YT; Held K
    Neuropharmacology; 2022 Apr; 207():108967. PubMed ID: 35077763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.